midaglizole has been researched along with Diabetes Mellitus, Adult-Onset in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (50.00) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellahsene, T; Dive, G; Godfroid, JJ; Guardiola-Lemaitre, B; Ktorza, A; Lamouri, A; Le Bihan, G; Manechez, D; Penicaud, L; Pfeiffer, B; Renard, P; Rondu, F; Touboul, E; Wang, X | 1 |
| Dive, G; Godfroid, JJ; Guardiola-Lemaître, B; Huet, J; Ktorza, A; Lamouri, A; Le Bihan, G; Lidy, S; Manéchez, D; Pelé-Tounian, A; Pénicaud, L; Pfeiffer, B; Renard, P; Rondu, F; Touboul, E; Wang, X | 1 |
| Ishihara, H; Kobayashi, S; Ohshima, K; Okada, S; Onai, T; Umahara, M | 1 |
| Harada, M; Harano, Y; Kashiwagi, A; Kojima, H; Nishio, Y; Shigeta, Y; Suzuki, M | 1 |
| Fukushima, H; Ichinose, K; Kishikawa, H; Miyata, T; Shichiri, M; Shinohara, M; Suzaki, K; Takeda, H | 1 |
| Akanuma, Y; Ishii, J; Kajinuma, H; Kanazawa, Y; Katagiri, H; Kawazu, S; Negishi, K; Sando, H; Suzuki, M; Yamanouchi, S | 1 |
6 other study(ies) available for midaglizole and Diabetes Mellitus, Adult-Onset
| Article | Year |
|---|---|
Design and synthesis of imidazoline derivatives active on glucose homeostasis in a rat model of type II diabetes. 1. Synthesis and biological activities of N-benzyl-N'-(arylalkyl)-2-(4',5'-dihydro-1'H-imidazol-2'-yl)piperazines .
Topics: Animals; Blood Glucose; Cattle; Diabetes Mellitus, Type 2; Disease Models, Animal; Drug Design; Glucose Tolerance Test; Homeostasis; Imidazoles; Male; Models, Molecular; Piperazines; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-2 | 1997 |
Design and synthesis of imidazoline derivatives active on glucose homeostasis in a rat model of type II diabetes. 2. Syntheses and biological activities of 1,4-dialkyl-, 1,4-dibenzyl, and 1-benzyl-4-alkyl-2-(4',5'-dihydro-1'H-imidazol-2'-yl)piperazines an
Topics: Animals; Blood Glucose; Cattle; Cerebral Cortex; Diabetes Mellitus, Type 2; Drug Design; Drug Evaluation, Preclinical; Glucose Tolerance Test; Homeostasis; Hypoglycemic Agents; Imidazoles; Imidazoline Receptors; In Vitro Techniques; Injections, Intraperitoneal; Insulin; Insulin Secretion; Kidney Cortex; Male; Piperazines; Rabbits; Radioligand Assay; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-2; Receptors, Drug; Structure-Activity Relationship | 1999 |
[A long survived case of malignant pheochromocytoma treated with alpha-methyl-p-tyrosine and midaglizol (DG-5128)].
Topics: Adrenal Gland Neoplasms; alpha-Methyltyrosine; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Humans; Imidazoles; Male; Methyltyrosines; Middle Aged; Pheochromocytoma; Prognosis; Tyrosine 3-Monooxygenase | 1990 |
New alpha 2-adrenergic blocker (DG-5128) improves insulin secretion and in vivo glucose disposal in NIDDM patients.
Topics: Adrenergic alpha-Antagonists; Blood Glucose; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Imidazoles; Infusions, Parenteral; Insulin; Insulin Infusion Systems; Kinetics; Somatostatin; Time Factors | 1986 |
Effect of alpha 2-adrenoceptor antagonist on platelet activation during insulin-induced hypoglycaemia in type 2 (non-insulin-dependent) diabetes mellitus.
Topics: Arginine Vasopressin; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Epinephrine; Female; Humans; Hypoglycemia; Hypoglycemic Agents; Imidazoles; In Vitro Techniques; Insulin; Male; Middle Aged; Platelet Aggregation; Reference Values | 1988 |
Initial phase II clinical studies on midaglizole (DG-5128). A new hypoglycemic agent.
Topics: Administration, Oral; Blood Glucose; Diabetes Mellitus, Type 2; Drug Evaluation; Female; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Imidazoles; Male; Middle Aged; Time Factors | 1987 |